The Positive Psychology Outcome Measure (PPOM) for people with dementia: Psychometric properties and factor structure by Stoner, CR et al.
1 
 
The Positive Psychology Outcome Measure (PPOM) for people with dementia: 
Psychometric properties and factor structure 
Charlotte R. Stoner1 PhD, BSc (Hons), Martin Orrell2 FRCPsych, PhD, and Aimee 
Spector PhD, DClinPsy, BSc3 
1 Department of Neurodegenerative Diseases, Institute of Neurology, University 
College London, UK. 
2 Institute of Mental Health, University of Nottingham, Nottingham, UK. 
3 Research Department of Clinical, Educational and Health Psychology, University 
College London, UK. 
 
Corresponding author 
Charlotte R. Stoner, Department of Neurodegenerative Disease, Institute of 
Neurology, National Office For Dementia Research, 27 Old Gloucester Street, 
University College London, WC1N 3AX, UK. c.stoner@ucl.ac.uk 
 
Conflict of Interest 
The authors declare no conflicting interests. 
 
Funding 
The current research was funded as part of a University College London (UCL) 
Grand Challenge of Human Wellbeing PhD project and was given support by the 
Clinical Research Network Portfolio. The PhD was linked to the Economic and Social 
Research Council (ESRC)/ NIHR funded PRIDE research programme. No funding 
bodies were involved in the design, collection, analysis, interpretation or writing of 
the manuscript. The views expressed are those of the authors and not necessarily 
those of the National Health Service (NHS), the NIHR or the Department of Health.  
 
 
2 
 
Acknowledgements 
The authors would like to thank Professor Esme Moniz-Cook, Doctor Catherine Hart, 
Lauren Sudgen, Amy Shipman, Joanne Sawyer, Lisa Thomson, and Sandra 
Simpson for their invaluable support and assistance with data collection. We would 
also like to thank University College London Grand Challenges and all the people 
who took part in this study.  
 
Author Contributions 
CS oversaw recruitment, analysed data and wrote the manuscript. AS acted as Chief 
Investigator for the study, provided supervisory support to CS and commented on 
drafts of the manuscript. MO provided supervisory support, statistical advice and 
commented on drafts on the manuscript.  
  
3 
 
Abstract 
Objectives: To conduct an in-depth psychometric assessment of the PPOM; a 
measure of hope and resilience. Method: An observational study at five NHS trusts 
across England. Participants either completed the study using self-complete or 
interview led procedures, dependent on their preference. Assessments were internal 
consistency, floor and ceiling effects, test-retest reliability, convergent validity and 
factor structure. Results: 225 participants were recruited and completed the study, 
with a subsample of 48 comprising the test-retest sample. Internal consistency was 
excellent α= .94, and significant correlations were observed between quality of life (r 
=.627, p<.001), depression (r= -.699, p<.001) and the Control, Autonomy, Self-
realisation and Pleasure Scale (CASP-19; r = .73, p<.001). The PPOM remained 
moderately stable over a one week period (ICC: 880) and factor analyses indicated a 
two-factor structure solution with acceptable fit indices. Discussion: The PPOM has 
robust psychometric properties and is now suitable for use research and practice. 
People who met the clinical criteria for depression where more likely to have lower 
scores on the PPOM, indicating criterion validity. Future work is needed to establish 
the PPOM as sensitive to change and to investigate the relationship between hope, 
resilience and depression further. 
Keywords: Alzheimer’s, reliability, validity, wellbeing. 
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Introduction 
In the last twenty years quality of life has become recognised as a key outcome in 
dementia. However, despite this, the research literature has an overriding focus on 
negative aspects of the experience of dementia so that there has been almost 
nothing on positive psychology perspectives, with quality of life virtually the only 
measure of positive outcome for people with dementia. Whilst it is often inferred that 
a reduction in negative symptoms will increase quality of life, there is a need to also 
cover positive domains that may increase or contribute to quality of life. The 
approach of positive psychology recognises that, whilst people with dementia can 
face difficulties and challenges in day-to-day life, they also have the capacity for a 
positive life and that positive emotions or traits can contribute to a greater quality of 
life (Efklides & Moraitou, 2013).  
 
Positive psychology (Seligman, 1998) theory refers to the study of positive emotions 
and traits that enable individuals, communities and organisations to thrive (Seligman, 
Steen, Park, & Peterson, 2005). Positive psychology focuses on the strengths and 
capabilities that people with dementia utilise in order to achieve or maintain 
wellbeing, in the face of difficulties or challenges faced, which has important 
implications for the understanding of wellbeing. However, a lack of gold standard 
outcome measures for people with dementia has hampered its evaluation within 
dementia research (Stoner, Orrell, & Spector, 2015).  
 
An earlier development and pilot study indicated that hope and resilience were 
important concepts for people with dementia (Stoner, Orrell, Long, Csipke, & 
Spector, 2017). Despite hope within dementia previously receiving little attention 
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(Cotter, 2009), qualitative analysis indicated that hope was multifaceted, present on 
a day to day basis and generalised in nature, as consistent with previous studies 
(Wolverson, Clarke, & Moniz-Cook, 2010). Resilience was deemed also to be 
present within daily life and was defined more ambiguously with some referring to it 
as a form of emotional stamina in the face of difficulties. Furthermore, these 
concepts were seen as integral to maintaining wellbeing in everyday life. Due to the 
perceived importance of these particular concepts, they were integrated into a new 
outcome measure, that acts as an exemplar of positive psychology measurement in 
dementia. Termed the Positive Psychology Outcome Measure (PPOM; Stoner, 
2017), the new 16-item measure consisted of an eight-item hope measure adapted 
from the Herth Hope Index (HHI; Herth, 1992) and an eight-item resilience measure 
developed with people with dementia, drawing on prominent theories of resilience 
within the literature (Connor & Davidson, 2003; Wagnild & Young, 1993).  
 
Preliminary data suggested good psychometric properties and important implications 
for wellbeing in dementia but the sample size (n=33) was too small for an in-depth 
analysis of psychometric properties, factor structure and validity in terms of 
relatedness to well researched concepts of quality of life and depression. Therefore, 
the aim of this study was to conduct an in-depth psychometric assessment of the 
PPOM in a sample of older adults with dementia. 
 
Methods 
Design 
A multi-site, observational study conducted at five National Health Service (NHS) 
trusts across England (Research Ethics Committee (REC) approval: 15/EE/0443). 
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The study was funded by a University College London (UCL) Grand Challenge of 
Human Wellbeing PhD study and consisted of one baseline questionnaire 
assessment and one retest assessment for a subsample of 48 participants. 
Measures could either be completed within an interview with a trained researcher or 
using a self-complete procedure. Methods for completion were discussed at point of 
contact with participants and was led by their preference.  
 
Participants 
Participants were recruited via the following avenues: 
1) Referrals from support groups, memory clinics and previous research 
2)  The Join Dementia Research (JDR) Register 
(https://www.joindementiaresearch.nihr.ac.uk). 
Participants were required to have a diagnosis of dementia according to DSM-IV 
criteria (American Psychiatric Association, 2000) and be deemed capable of 
providing informed consent. These inclusion criteria were purposefully all-
encompassing to ensure that a wide range of people living with dementia were able 
to participate. 
 
Procedure 
Research assistants and clinical support officers at each NHS trust were responsible 
for identifying potential participants. Eligible participants were contacted to ascertain 
interest in the study and to establish capacity to give consent, via an informal 
capacity assessment. Staff at NHS trusts were also responsible for discussing 
participant preference with regard to manner of completion (interview or self-report). 
Participants were informed that that the questionnaire booklet could be sent to their 
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address by post or email with a freepost return envelope, or that a research assistant 
could visit them at a place and time of their convenience to assist them with 
completion. Participants were encouraged to select the completion style that was 
most suitable for them. Instructions for self-completion and interview procedures 
were standardised across sites, ensuring that both methodologies were consistent 
across participants and sites.  
 
Outcome Measures 
Demographic and clinical information consisting of age, gender, ethnicity, dementia 
diagnosis, diagnosis date and current medication was collected. Participants were 
also asked to list any co-morbid ‘major mental or physical health problems’ they were 
currently experiencing. No restrictions were put on these additional diagnoses. Four 
outcome measures were selected to ascertain the convergent validity of the PPOM. 
These, in addition to the PPOM, are described below. 
 
The Positive Psychology Outcome Measure (PPOM) 
The PPOM measures the degree of hope and resilience for people with dementia. It 
is measured on a five-point Likert scale (0- not true at all, 4- true nearly all the time) 
and uses a one-month time frame (Stoner, Orrell, Long, Csipke, & Spector, 2017). It 
has an excellent level of internal consistency (α = .939; Stoner, 2017).  
 
The Control, Autonomy, Self-realisation and Pleasure Scale (CASP-19) 
Building on humanist psychology (Maslow, 1968), it views wellbeing as the 
satisfaction of four domains: control, autonomy, self-realisaton and pleasure. Each of 
the 19 questions is rated on a four-point Likert scale (0- never, 3 often), with higher 
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scores reflecting increased satisfaction across domains. It was developed for older 
adults, for which adequate psychometric properties were reported and evidence 
emerged for a second order, latent quality of life factor solution (Hyde, Wiggins, 
Higgs, & Blane, 2003). The CASP-19 was assessed psychometrically as part of this 
study (Stoner, 2017).  
 
The Geriatric Depression Scale Short Form (GDS-15) 
The GDS consists of 15 dichotomous items (yes/ no), and was designed as a self-
complete measure. A score of between 5-9 indicates mild depression, whilst a score 
of 10 or higher indicates severe and significant depression with a sensitivity 
specificity ratio of 84%: 95% (Yesavage, Brink, Rose, & Adey, 1983). The GDS has 
adequate psychometric properties for people with dementia (Lesher & Berryhill, 
1994).  
 
The Quality of Life in Alzheimer’s Disease Scale (QoL-AD) 
The QoL-AD consists of 13 items measured on a 4-point Likert scale, with scores 
ranging from 13 to 52 with higher scores indicate a better quality of life across 
domains. It can be used as a self-complete measure or within an interview, has an 
acceptable reported level of internal consistency (0.77-0.84) (Logsdon, Gibbons, 
McCurry, & Teri, 1999) and has demonstrated convergent validity with other quality 
of life (Thorgrimsen, et al., 2003) and health related measures (Wolak-Thierry, et al., 
2015). 
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Analysis 
A combination of mean and multiple imputations was selected to adjust for missing 
data. Mean imputation was conducted at the 10% level for the PPOM, GDS and 
CASP-19. The QoL-AD was imputed at the 20% level, based on previous studies 
(Logsdon, Gibbons, McCurry, & Teri, 1999). Following this, multiple imputation 
(Rubin, 1987) was applied at a measure level using 20 imputations as possible 
alternatives.  
 
Measure norms and floor and ceiling effects were assessed using the mean, 
standard deviation, range and possible range. If less than 15% of respondents 
achieved the highest or lowest possible sores, ceiling and floor effects were not 
considered significant (Terwee, et al., 2007). Cronbach Alpha’s were calculated to 
assess internal consistency at a measure and subscale level. To assess stability, 
Intraclass Correlation Coefficients (ICC) were used to assess linear agreement 
within a one-week period. To assess convergent validity (the degree to which 
concepts that are theoretically related are observed to be related on outcome 
measures of such concepts), Pearson’s R correlations were calculated. It was 
hypothesised that a positive correlation would be observed between the PPOM and 
both the QoL-AD and CASP-19, and a negative correlation would be observed 
between the PPOM and GDS. 
 
Factor structure was examined using best practice procedures. Firstly, data was 
randomly halved using SPSS and halves were labelled either ‘construction’ or 
‘validation’. Construction data was imported into MPlus and syntax was entered to 
conduct an Exploratory Factor Analysis (EFA) to identify the amount of ‘latent’ 
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factors, or variables that were not overtly measured, and are usually denoted by an 
eigenvalue of one or greater (Kaiser, 1960). Factors identified within the EFA were 
then applied as Confirmatory (CFA) using the remaining validation data. To establish 
whether the proposed model was adequate, goodness of fit indexes were then used 
including chi-squared statistics, comparative fit index (CFI), standardised room mean 
square residuals (SRMR) and root mean square error of approximation (RMSEA). 
CFI values greater than .90 are generally acceptable, whilst SRMR values should be 
below .08. RMSEA values between .06 and .08 suggests acceptable model fit (Hu & 
Bentler, 1999). However, these values are considered guidelines with alternatives 
being suggested elsewhere (Schumacker, 2015).  
 
Results 
Participants 
Participants consisted of 225 people with dementia (129 males and 96 females; 
Table 1), who were deemed capable of providing informed consent following an 
informal capacity assessment. Participants were, on average, 77.1 years of age (SD 
= 9.4), were most likely to have been diagnosed with Alzheimer’s disease and had 
been living with dementia for under a year (Table 2). Depression was the most 
frequently reported co-morbid diagnosis, but examples of other diagnoses were 
diabetes (n = 11), cancer (n = 4), alcoholism (n = 1).  
 
INSERT TABLE 1 AND 2 HERE 
 
Internal Consistency 
11 
 
Internal consistency was very good with α= .94 and with no items identified as 
improving the internal consistency if deleted, meaning the PPOM had an adequate 
level of content validity. For the hope subscale, internal consistency was α=. 877 
and, again, no items were identified as improving the internal consistency if 
removed. The resilience subscale had an internal consistency of α=. 919 with no 
items identified as improving the internal consistency if deleted. 
 
Floor and Ceiling Effects 
Possible scores ranged from 0- 64 and the observed range was 6-64 with a mean of 
48.15 and standard deviation of 12.24. Analysis indicated that the PPOM was 
moderately, negatively skewed (- .83) and the kurtosis value was .354. No 
participants scored the lowest possible (0) and 14 participants achieved the 
maximum possible score of 64. This represented only 6.48% of the sample and 
therefore neither floor or ceiling effects for the PPOM were problematic. 
 
Test-Retest Reliability 
Consistency between the PPOM at test and retest was moderate (ICC= .687), with a 
Confidence Interval (CI) of .499 and .813. However, two outliers were identified. One 
participant scored 58 at baseline, whilst scoring 20 at retest and another participant 
scored 21 at baseline, whilst scoring 58 at retest. After these cases were removed 
from the analysis, consistency greatly improved with an ICC value of .880 and 95% 
CIs of .788 and .934. At a subscale level, consistency was ‘good’. The resilience 
subscale had an ICC value of .906, with a 95% CI from .832 to .948 and the hope 
subscale was considered moderate (ICC= .783), with a 95% CI of .632 to .877. 
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Convergent Validity 
Both the hope and resilience subscales were significantly correlated with the QoL-
AD (r =.597, p<.001; r =.548, p<.001), as was the measure total (r =.627, p<.001). 
The PPOM was also positively correlated with the CASP-19 (r = .73, p<.001), as 
were both the hope and resilience subscales (r = .699, p<.001; r = .642, p<.001), 
indicating convergent validity. A negative correlation was observed between both 
hope and resilience subscales (r = -.675, p<.001; r= -.594 p<.001) and between the 
GDS and PPOM total (r= -.699, p<.001). An independent samples t-test indicated 
that people who scored less than five on the GDS (n = 151), indicating few or no 
depressive symptoms, scored significantly higher on the PPOM (M= 52.25 SEM=.82) 
than those who scored ten or greater (n = 26) on the GDS (M= 29.38 SEM= 2.3) (t 
(1298723)= 10.497, p<.001), indicating those likely to have depressive 
symptomology were more likely to score lower on the PPOM.  
 
Factor Structure 
Eigenvalues during the EFA stage indicated the presence of two factors (8.574 and 
1.142). Loadings indicated that items loaded onto two factors successfully, with all 
hope items significantly loading onto factor one and all resilience items significantly 
loading onto a second factor.   
 
Fit indices were acceptable when this model was applied to validation half of data 
within the CFA stage and, whilst the chi-square analysis was significant, fit indices 
indicated acceptable fit when all data was integrated and the CFA re-run. All items 
significantly loaded onto their respective factor and a co-variance analysis indicated 
there was some shared variance between the hope and resilience factor (Figure 1). 
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Factor loadings at this stage ranged from 0.468 - 1.293. The two latent factors 
shared some covariance again (r = .5) and the average variance explained by the 
two factors was 𝑅"= .55 for hope and 𝑅"= .61 for resilience. 
 
INSERT FIGURE 1 HERE 
 
Discussion 
Summary of Results 
Overall the psychometric properties of the PPOM were satisfactory, supporting its 
suitability for research and clinical practice. Internal consistency of the PPOM was 
acceptable as was test-retest reliability. Whilst test-retest reliability was not absolute, 
as it rarely would be, the range of moderate to good suggests that hope and 
resilience for people with dementia, whilst subject to some fluctuation, largely remain 
stable. Only two participants were identified as fluctuating largely. All other measures 
remained stable and these participants did not identify any mental/ physical health 
problems or changes to medication between baseline and retest. It is, therefore, 
difficult to draw conclusions. It may be that there was a significant life event that this 
study was not designed to pick up, or it may be that for this particular participant 
hope and resilience were more of a state rather than an ingrained personality trait 
and, therefore, subject to variability (Chaplin, John, & Goldberg, 1988).  
 
Correlations were in the expected direction and statistically significant. Whilst 
statistically significant, clinical significance is harder to define, as there are no other 
studies to compare the results here with. It is suggested that correlations above r 
=.40 are ‘moderate’ whilst r =.60 - .79 are ‘strong’ (Evans, 1996). However, it has 
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also been suggested that correlations above .40 should be considered clinically 
significant (Dunn, 2000). Correlations any higher here may have indicated that 
positive measures were conceptually identical to existing quality of life measures. As 
such, moderate correlations were considered clinically significant and indicative that 
these measures, whilst measuring positive concepts, were distinct from quality of life.  
 
Analysis of the PPOM indicated that both a one-factor and a two-factor solution 
might be appropriate, as some items loaded onto both factors. This may be 
attributable to the presence of hope contributing to adaptive recovery from stress 
(Ong, Edwards, & Bergeman, 2006). However, whilst related, the two are distinct 
concepts within the literature and consequently it was more appropriate to treat them 
as such and use a two-factor model, in which the factors were allowed to share 
covariance. Whilst two items loaded onto both factors, in no instance did an item 
load onto the incorrect factor, further providing evidence for a two-factor solution.  
 
Future Research and Implications for Practice 
The PPOM represents an important addition to the quantitative positive psychology 
literature. The ability of people with dementia to retain and use character strengths 
has been documented to some degree in the qualitative literature, but prior to this 
study, no measures of these concepts for people with dementia existed. This 
research, therefore, represents a first step in quantitatively assessing positive 
psychology for people with dementia. Furthermore, the significant correlation 
between the PPOM and QoL-AD provide evidence for hope as a trait like personal 
strength which underpins wellbeing in dementia (Kitwood & Bredin, 1992) and 
supports previous work detailing the contribution of positive emotions to quality of life 
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in dementia (Wolverson & Clarke, 2016). It is therefore possible that by acting upon 
traits such as those measured within the PPOM, vicarious benefits to quality of life 
may be observed and supports the addition of the PPOM to studies examining 
quality of life outcomes using psychosocial interventions.  
 
The high levels of hope reported here counteract narratives that reinforce 
hopelessness, with dementia portrayed as a tragic loss of a person (Peele, 2014) 
and the PPOM indicates levels of hope and resilience have been underestimated in 
dementia. For older adults receiving palliative care, the psychosocial benefits, 
including an increased quality of life, of hope fostering interventions has been noted 
(Duggleby, et al., 2007). It is possible that this benefit could also be observed in 
older adults with dementia, and the PPOM would be an accurate tool to measure the 
effect of such interventions. However, to our knowledge, no such interventions have 
been attempted within dementia research.   
 
Most commonly, resilience is referred to as a dynamic psychosocial behaviour that 
can be learned (Allen, Haley, Harris, Fowler, & Pruthi, 2011). However, much of the 
existing literature base for resilience in dementia is based on a high and low 
resilience framework (e.g. Windle, 2012), with few studies identifying the processes 
by which resilience might be learned in dementia. Evidence here suggests that, 
whilst subject to some variability, resilience remained moderately stable over a one-
week period. Again, whilst noted in the qualitative literature as an important means of 
retaining autonomy and wellbeing, no interventions for building resilience for people 
with dementia exist, with resilience interventions targeted at carers of those with 
dementia (e.g. Gaugler, Kane & Newcomer, 2007). This may be due to a lack of 
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available measures and consequently, the PPOM represents an important 
contribution to the evaluation of resilience in people with dementia.  
 
Results indicate that the PPOM is a robust measure that may now be used in further 
research for people with dementia. Whilst the psychometric property assessment 
here was extensive, an important aspect of psychometric theory, namely measure 
responsiveness or sensitivity to change (Stratford & Riddle, 2005), could not be 
established within the current study. However, the PPOM will be used as secondary 
outcomes to assess the efficacy of an Economic and Social Research Council 
(ESRC) funded social intervention in maintaining independence for people with mild 
dementia (Promoting Independence in Dementia ‘PRIDE’ Research Programme). 
This is an important step in garnering whether, if at all, the measures are able to pick 
up change as a result of this intervention. Furthermore, it will provide quantitative 
evidence as to whether positive concepts such as hope or resilience can be acted 
upon for people with dementia to induce improvements in concepts such as 
wellbeing or quality of life. This relationship has previously only been explored 
qualitatively.  
 
Whilst much research for people with dementia is concerned with reducing 
behavioural and psychological symptoms of dementia such as agitation or 
depression (Livingston, et al., 2005), positive psychology research for this population 
is still lacking. Much resides in the qualitative literature such as studies examining 
the strengthening of a relationship between a person with dementia and a supporter 
(Quinn, Clare, McGuiness & Woods, 2012) and a book outlining positive psychology 
approaches to dementia (Clarke & Wolverson, 2016). It is suggested that, in addition 
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to research aimed at reducing negative symptoms for people with dementia, 
research around developing interventions to foster hope and resilience for people 
with dementia is needed to explore how, if at all, concepts can be acted upon to 
improve wellbeing. 
 
Methodological Problems and Limitations 
Whilst randomly splitting data into construction and validation halves is best practice 
for structural equation modelling (SEM), this meant that the number of data points 
were substantially reduced at each stage. This may have impacted upon results, 
making models identified within the EFA stage more difficult to confirm within the 
CFA stage. Furthermore, sample sizes are known to impact upon the Chi-Squared 
goodness of fit statistic to the degree that small changes can have a large impact 
upon results. To ensure that the proposed model is the best possible fit for the 
observed data, further and more large-scale research is needed. 
 
The main limitation was the lack of representation of Black, Asian and Minority 
Ethnic (BAME) groups. This may be due to a lack of diversity at sites to begin with or 
that research avenues were not sufficient enough to ensure representation. As such, 
the majority of this data reflects positive psychology concepts in White- British 
people and little can be said about the possible cross-cultural implications. 
 
Proxy ratings (i.e. by carers) were not included within this study. Whilst this enabled 
people who could not identify carers to take part in the research, it is noted that no 
inferences can be made as potential differences between self and proxy perceptions 
of these positive concepts. However, within the qualitative literature, people with 
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dementia have been accurately able to explore these concepts in great detail 
(Wolverson, Clarke, & Moniz-Cook, 2016) and, therefore, proxy ratings were not 
considered as in keeping with the theoretical underpinning of this research. 
Furthermore, participants all had capacity to consent in research and, consequently, 
were more likely to be in milder stages of dementia. Cognition was not assessed as 
part of this study and, therefore, it is not possible, to make inferences about the 
progression of hope and resilience across the course of dementia. Whilst not 
necessary for a psychometric evaluation, future researchers may wish to explore this 
area.  
 
Whilst the GDS has previously been assessed psychometrically within a dementia 
population (Lesher & Berryhill, 1994), it is noted that the validity of this measure is 
sometimes questioned for people with dementia (Kørner, et al., 2006). In particular, 
the sensitivity and specificity of the GDS has been suggested as declining as 
dementia severity increases (Müller-Thomsen, et al., 2005). However, in mild to 
moderate dementia, the GDS has been established as a valid measure (Feher, 
Larrabee & Crook, 1992), although awareness of memory deficits was linked to 
accuracy of self-report. As participants here were all deemed capable of providing 
informed consent and, consequently, more likely to be in the milder stages of 
dementia, it is likely that the GDS was an accurate measure of depressive symptoms 
within the current study. For participants in the more severe stages of dementia, the 
Cornell Scale for Depression in Dementia (CSDD; Alexopoulos, Abrams, Young & 
Shamoian, 1988) may be a more appropriate means of assessing convergent validity 
with the PPOM. 
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The current study was designed to be short, requiring minimal effort for a person with 
dementia to complete the study, and allowing them to take part either as either self-
reporters or by interview. Whilst the study employed two methodologies (self-report 
and interview) and this may have led to variability in completion, no significant 
differences were observed between groups suggesting such effects were minimal. 
Furthermore, measures selected were brief in nature and assessments of 
convergent validity were limited to quality of life and depression. It is noted that other 
concepts such as apathy are related to levels of hope (Rodriguez-Hanley & Snyder, 
2000) and to resilience (Robottom et al., 2012) and future studies may wish to 
explore this.  
 
Conclusions 
The PPOM demonstrated satisfactory psychometric properties, in an area of 
research that has been neglected for people with dementia. The PPOM 
demonstrated significant correlations with both quality and life and depression 
suggesting that levels of hope and resilience have important implications for 
wellbeing in dementia. Future work will entail assessing the ability of the PPOM to 
detect change within psychosocial interventions and it is hoped that this will help to 
facilitate a strengths and capabilities based approach to future dementia research. A 
copy of the PPOM and scoring information is available from the corresponding 
author upon request. It is free to use but should be referenced accordingly.  
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Table 1 Participant Demographics 
 Total Sample 
(n =225) 
Subsample 
(n =48) 
Gender n (%) 
Male 
Female 
 
129 (57.3) 
96 (42.7) 
 
29 (60.4) 
19 (39.6) 
Age M (SD) Range 77.1 (9.4) 50-99 76.63 (10.2) 59-
99 
Marital status n (%) 
   Single 
   Married 
   Widowed 
   Divorced 
Other 
 
 
9 (4) 
147 (65.3) 
51 (22.7) 
13 (5.8) 
5 (2.2) 
 
5 (10.4) 
30 (62.5) 
9 (18.8) 
2 (4.2) 
2 (4.2) 
Ethnicity n (%) 
   White (British) 
   White (other) 
   Black 
Asian 
Mixed 
Unknown (missing) 
 
 
201 (89.3) 
10 (4.4) 
4 (1.8) 
3 (1.3) 
1 (0.4) 
6 (2.7) 
 
 
44 (91.7) 
3 (6.3) 
1 (2.1) 
0 (0) 
0 (0) 
0 (0) 
 
 
Table 2: Participant Clinical Characteristics 
 Total Sample 
(n = 225)  
Subsample 
(n =48) 
Dementia diagnosis n (%) 
   Alzheimer’s disease 
   Vascular dementia 
   Dementia of mixed aetiology 
   Parkinson’s related dementia 
Other 
Dementia (variant unknown) 
 
109 (48.4) 
40 (17.8) 
47 (20.9) 
4 (1.8) 
9 (3.9) 
19 (8) 
 
 
25 (52.1) 
8 (16.7) 
8 (16.7) 
3 (6.3) 
3 (6.3) 
1 (2.1) 
 
Time since diagnosis n (%) 
   <1 year 
   1- 3 years 
   3>  years 
   Unknown 
 
 
73 (32.4) 
92 (40.9) 
42 (18.6) 
18 (8) 
 
17 (35.4) 
19 (39.6) 
9 (18.8) 
3 (6.3) 
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Acetylcholinesterase inhibitor n (%) 
   None 
   Donepezil 
   Other 
    
Other major mental or physical health 
problem n (%) 
   None 
   Depression 
Other 
 
88 (39.1) 
90 (40) 
47 (20.9) 
 
 
 
167 (74.2) 
17 (7.6) 
41 (18.2) 
 
18 (37.5) 
17 (35.4) 
13 (27.1) 
 
 
 
34 (70.8) 
2 (4.2) 
10 (25) 
Other psychotropic medication n (%) 
   None 
   Antidepressant 
Other 
 
186 (82.7) 
26 (11.6) 
13 (5.7) 
 
41 (85.4) 
4 (8.3) 
3 (6.3) 
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Figure 1 Factor Loadings  
 
